A Trial to Study the Absorption, Metabolism, and Excretion of [14C]-Olinciguat in Healthy Male Volunteers

NCT03795519 PHASE1 COMPLETED

The primary objective is to characterize the pharmacokinetics (PK) of olinciguat and total radioactivity and to assess the elimination of total radioactivity from a single oral dose of \[14C\]-olinciguat.

Details

Lead sponsor	Cyclerion Therapeutics
Phase	PHASE1
Status	COMPLETED
Enrolment	8
Start date	Thu Jan 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed Feb 27 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Healthy Volunteers

Interventions

• [14C]-olinciguat

Countries

United States